US4542025A
(en)
|
1982-07-29 |
1985-09-17 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
US4945050A
(en)
|
1984-11-13 |
1990-07-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
US5071773A
(en)
|
1986-10-24 |
1991-12-10 |
The Salk Institute For Biological Studies |
Hormone receptor-related bioassays
|
US5573933A
(en)
|
1987-04-14 |
1996-11-12 |
Luminis Pty, Ltd. |
Transgenic pigs
|
US5532220A
(en)
|
1987-08-31 |
1996-07-02 |
The Regents Of The University Of California |
Genetic mechanisms of tumor suppression
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
US5240846A
(en)
|
1989-08-22 |
1993-08-31 |
The Regents Of The University Of Michigan |
Gene therapy vector for cystic fibrosis
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
US5633076A
(en)
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
US6316003B1
(en)
|
1989-12-21 |
2001-11-13 |
Whitehead Institute For Biomedical Research |
Tat-derived transport polypeptides
|
US5652122A
(en)
|
1989-12-21 |
1997-07-29 |
Frankel; Alan |
Nucleic acids encoding and methods of making tat-derived transport polypeptides
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
JPH07500961A
(ja)
|
1990-10-01 |
1995-02-02 |
ユニバーシティ オブ コネチカット |
細胞による選択的内在化を目的としたウイルス及び細胞の標的設定
|
US5831141A
(en)
|
1991-01-11 |
1998-11-03 |
United States Of America As Represented By The Department Of Health And Human Services |
Expression of a heterologous polypeptide in mammary tissue of transgenic non-human mammals using a long whey acidic protein promoter
|
AU668870B2
(en)
|
1991-05-14 |
1996-05-23 |
Targetech, Inc |
Targeted delivery of genes encoding immunogenic proteins
|
AU2160992A
(en)
|
1991-06-05 |
1993-01-12 |
Board Of Regents Acting For And On Behalf Of The University Of Michigan, The |
Targeted delivery of genes encoding secretory proteins
|
AU3434393A
(en)
|
1992-01-17 |
1993-08-03 |
Regents Of The University Of Michigan, The |
Targeted virus
|
US5338843A
(en)
|
1992-01-30 |
1994-08-16 |
Becton, Dickinson And Company |
Fluorogenic and chromogenic β-lactamase substrates
|
CA2133411A1
(en)
|
1992-04-03 |
1993-10-14 |
Alexander T. YOUNG |
Gene therapy using targeted viral vectors
|
US5565324A
(en)
|
1992-10-01 |
1996-10-15 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
JP3789930B2
(ja)
|
1992-10-09 |
2006-06-28 |
アドバンスド ティシュー サイエンシズ,インコーポレーテッド |
肝予備細胞
|
AU680459B2
(en)
|
1992-12-03 |
1997-07-31 |
Genzyme Corporation |
Gene therapy for cystic fibrosis
|
ATE247171T1
(de)
|
1993-04-21 |
2003-08-15 |
Univ Edinburgh |
Expression von heterologen genen nach einem ziel- expressionsprofil
|
JP3626187B2
(ja)
|
1993-06-07 |
2005-03-02 |
バイカル インコーポレイテッド |
遺伝子治療に適するプラスミド
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
US5962427A
(en)
|
1994-02-18 |
1999-10-05 |
The Regent Of The University Of Michigan |
In vivo gene transfer methods for wound healing
|
US5942496A
(en)
|
1994-02-18 |
1999-08-24 |
The Regent Of The University Of Michigan |
Methods and compositions for multiple gene transfer into bone cells
|
FR2718329B1
(fr)
|
1994-03-21 |
2002-09-20 |
Rhone Poulenc Rorer Sa |
Lapin transgénique sensibilisé aux dyslipoprotéinémies.
|
US5675060A
(en)
|
1994-05-19 |
1997-10-07 |
Institut National De La Sante Et De La Recherche Medicale |
Transgenic arthritic mice expressing a T-cell receptor transgene
|
US5850001A
(en)
|
1994-06-06 |
1998-12-15 |
Universite De Montreal |
Transgenic mouse for the neuronal expression of HIV gp160
|
US5907030A
(en)
|
1995-01-25 |
1999-05-25 |
University Of Southern California |
Method and compositions for lipidization of hydrophilic molecules
|
US5669907A
(en)
|
1995-02-10 |
1997-09-23 |
Valleylab Inc. |
Plasma enhanced bipolar electrosurgical system
|
US5814300A
(en)
|
1995-03-03 |
1998-09-29 |
Cephalon, Inc. |
Gene-targeted non-human mammals deficient in the SOD-1 gene
|
US5741657A
(en)
|
1995-03-20 |
1998-04-21 |
The Regents Of The University Of California |
Fluorogenic substrates for β-lactamase and methods of use
|
US5751629A
(en)
|
1995-04-25 |
1998-05-12 |
Irori |
Remotely programmable matrices with memories
|
ATE365808T1
(de)
|
1995-07-28 |
2007-07-15 |
Marie Curie Cancer Care |
Transportproteine und deren verwendungen
|
FR2739621B1
(fr)
|
1995-10-05 |
1997-12-05 |
Centre Nat Rech Scient |
Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
|
DE69632989T2
(de)
|
1995-10-17 |
2005-08-25 |
Combichem, Inc., San Diego |
Matrize für die Synthese kombinatorischer Bibliotheken in Lösung
|
US5846946A
(en)
|
1996-06-14 |
1998-12-08 |
Pasteur Merieux Serums Et Vaccins |
Compositions and methods for administering Borrelia DNA
|
EP0920445B1
(fr)
|
1996-08-23 |
2003-01-02 |
Sederma S.A. |
Peptides synthetiques et leur utilisation dans les compositions cosmetiques ou dermopharmaceutiques
|
CA2468374C
(en)
|
1996-08-30 |
2010-12-21 |
Novo-Nordisk A/S |
Glp-1 derivatives
|
US5928888A
(en)
|
1996-09-26 |
1999-07-27 |
Aurora Biosciences Corporation |
Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities
|
US5906923A
(en)
|
1996-10-02 |
1999-05-25 |
Incyte Pharmaceuticals, Inc. |
ATPase inhibitor
|
US5798035A
(en)
|
1996-10-03 |
1998-08-25 |
Pharmacopeia, Inc. |
High throughput solid phase chemical synthesis utilizing thin cylindrical reaction vessels useable for biological assay
|
GB9714680D0
(en)
|
1997-07-11 |
1997-09-17 |
Medical Res Council |
Recombinant production of proteins
|
US6093692A
(en)
|
1997-09-25 |
2000-07-25 |
The University Of Southern California |
Method and compositions for lipidization of hydrophilic molecules
|
EP1060191B1
(en)
|
1998-02-27 |
2010-04-28 |
Novo Nordisk A/S |
Derivatives of glp-1 analogs
|
GB9814527D0
(en)
|
1998-07-03 |
1998-09-02 |
Cyclacel Ltd |
Delivery system
|
FR2783169B1
(fr)
|
1998-09-15 |
2001-11-02 |
Sederma Sa |
Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)
|
US6492326B1
(en)
|
1999-04-19 |
2002-12-10 |
The Procter & Gamble Company |
Skin care compositions containing combination of skin care actives
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
US7229961B2
(en)
|
1999-08-24 |
2007-06-12 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into ocular tissues
|
US8183339B1
(en)
|
1999-10-12 |
2012-05-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
US20030026781A1
(en)
|
1999-11-10 |
2003-02-06 |
Mitokor |
Compositions and methods for regulating endogenous inhibitor of ATP synthase, including treatment for diabetes
|
JP2003527835A
(ja)
*
|
1999-11-10 |
2003-09-24 |
マイトコー |
Atpシンターゼにおける調節内因性インヒビター
|
US20040072739A1
(en)
|
1999-11-10 |
2004-04-15 |
Anderson Christen M. |
Compositions and methods for regulating endogenous inhibitor of ATP synthase, including treatment for diabetes
|
SE0002232D0
(sv)
|
2000-06-15 |
2000-06-15 |
Vulpes Ltd |
Antioxidant
|
JP2005508832A
(ja)
|
2001-02-16 |
2005-04-07 |
セルゲイト, インコーポレイテッド |
間隔を開けてアルギニン部分を含むトランスポーター
|
US7049286B2
(en)
|
2001-08-30 |
2006-05-23 |
Diatos, S.A. |
Insulin conjugates and methods of use thereof
|
FR2830195B1
(fr)
|
2001-10-03 |
2004-10-22 |
Sederma Sa |
Compositions cosmetiques et dermopharmaceutiques pour les peaux a tendance acneique
|
ATE510852T1
(de)
|
2001-10-30 |
2011-06-15 |
Dsm Ip Assets Bv |
Dermopharmazeutisch und kosmetisch wirksame oligopeptide
|
TW200408407A
(en)
|
2001-11-30 |
2004-06-01 |
Dana Farber Cancer Inst Inc |
Methods and compositions for modulating the immune system and uses thereof
|
FR2836042B1
(fr)
|
2002-02-15 |
2004-04-02 |
Sederma Sa |
Compositions cosmetiques ou dermopharmaceutiques pour diminuer les poches et cernes sous les yeux
|
CA2785889A1
(en)
|
2002-04-22 |
2003-10-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
Peptide inhibitors of protein kinase c
|
SE0201863D0
(en)
|
2002-06-18 |
2002-06-18 |
Cepep Ab |
Cell penetrating peptides
|
KR101116528B1
(ko)
|
2003-05-08 |
2012-02-28 |
디에스엠 아이피 어셋츠 비.브이. |
피부구조를 향상시키는 트리펩타이드 및 그 유도체의 미용용도
|
US7208595B2
(en)
|
2003-07-25 |
2007-04-24 |
The Ohio State University Research Foundation |
Peptide deformylase inhibitors as novel antibiotics
|
US9695251B2
(en)
|
2003-10-31 |
2017-07-04 |
The Regents Of The University Of California |
Activatable cell penetrating peptides with quenched fluorophores
|
US7431915B2
(en)
|
2003-10-31 |
2008-10-07 |
The Regents Of The University Of California |
Peptides whose uptake by cells is controllable
|
US7985401B2
(en)
|
2003-10-31 |
2011-07-26 |
The Regents Of The University Of California |
Peptides whose uptake by cells is controllable
|
JP4256389B2
(ja)
|
2003-11-17 |
2009-04-22 |
セダーマ |
テトラペプチドとトリペプチドの混合物を含む組成物
|
CA3031270A1
(en)
|
2004-03-03 |
2005-12-22 |
Revance Therapeutics, Inc. |
Compositions and methods for topical diagnostic and therapeutic transport
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
US7265092B2
(en)
|
2004-09-30 |
2007-09-04 |
Kai Pharmaceuticals, Inc. |
Pharmaceutical formulation
|
RU2007136616A
(ru)
|
2005-03-03 |
2009-04-10 |
Риванс Терапьютикс, Инк. (Us) |
Композиция и способ для местного применения и чрескожного введения ботулинового токсина
|
US8080517B2
(en)
|
2005-09-12 |
2011-12-20 |
Xigen Sa |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
US7659252B2
(en)
|
2005-09-15 |
2010-02-09 |
Novomed Technologies, Inc. (Shanghai) |
Transdermal delivery peptides and method of use thereof
|
WO2007035474A2
(en)
|
2005-09-15 |
2007-03-29 |
Novomed Technologies, Inc. (Shanghai) |
Transdermal delivery peptides and method of use thereof
|
EP1984387B1
(en)
|
2006-02-16 |
2017-05-31 |
Sederma |
Polypeptides kxk and their use
|
WO2007108749A1
(en)
|
2006-03-20 |
2007-09-27 |
Cepep Iii Ab |
Chimeric constructs between cancer-homing peptides and cell-penetrating peptides coupled to anticancer drugs and/or diagnostic agent/agents
|
AU2007232206B2
(en)
|
2006-03-30 |
2013-04-04 |
Drais Pharmaceuticals, Inc. |
Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same
|
CN101583274A
(zh)
|
2006-12-29 |
2009-11-18 |
雷文斯治疗公司 |
使用反向序列hiv-tat多肽的运输分子
|
KR102274003B1
(ko)
|
2007-01-19 |
2021-07-08 |
카이 파마슈티컬즈 |
안정성 및 전달 효율을 증가시키기 위한 펩타이드 조성물의 변형
|
WO2009036092A2
(en)
|
2007-09-10 |
2009-03-19 |
University Of Massachusetts |
Mitochondria-targeted anti-tumor agents
|
EP2653543A1
(en)
|
2008-02-05 |
2013-10-23 |
Bicycle Therapeutics Limited |
Methods and Compositions
|
ES2330291B1
(es)
|
2008-02-29 |
2010-10-18 |
Lipotec Sa |
Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
|
CN102119217B
(zh)
|
2008-04-15 |
2015-06-03 |
普洛体维生物治疗公司 |
用于核酸递送的新型制剂
|
WO2010039088A1
(en)
|
2008-09-16 |
2010-04-08 |
Kariem Ahmed |
Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds
|
US20100311671A1
(en)
|
2009-03-25 |
2010-12-09 |
Kai Pharmaceuticals |
Transdermal delivery of pkc modulatory peptides through microporated skin
|
EP2454271A4
(en)
|
2009-07-15 |
2015-08-12 |
Univ California |
PEPTIDES WITH CONTROLLABLE CELLULAR RECORDING
|
US8946166B2
(en)
|
2009-07-24 |
2015-02-03 |
Lipotec, S.A. |
Peptide-based compounds and compositions which inhibit muscle contraction
|
US20130053433A1
(en)
|
2010-01-06 |
2013-02-28 |
The University Of North Carolina At Chapel Hill |
Fatty acid derivatives and analogs of drugs
|
CA2800741C
(en)
|
2010-05-30 |
2018-07-24 |
The Governing Council Of The University Of Toronto |
Mitochondrial penetrating peptides as carriers for anticancer compounds
|
US20130078295A1
(en)
|
2010-06-09 |
2013-03-28 |
Lipotec S.A. |
Skin antiaging treatment
|
WO2012000104A1
(en)
|
2010-06-30 |
2012-01-05 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
US9408542B1
(en)
|
2010-07-22 |
2016-08-09 |
Masimo Corporation |
Non-invasive blood pressure measurement system
|
CN104531812A
(zh)
|
2010-10-01 |
2015-04-22 |
现代治疗公司 |
设计核酸及其使用方法
|
CA2811113A1
(en)
|
2010-11-09 |
2012-05-18 |
The Regents Of The University Of California |
Skin permeating and cell entering (space) peptides and methods of use thereof
|
JP6091435B2
(ja)
|
2011-02-22 |
2017-03-08 |
カリフォルニア インスティチュート オブ テクノロジー |
アデノ随伴ウイルス(aav)ベクターを用いたタンパク質の送達
|
ES2397890B1
(es)
|
2011-03-25 |
2014-02-07 |
Lipotec, S.A. |
Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas.
|
EA201301173A1
(ru)
|
2011-04-15 |
2015-08-31 |
Дженелюкс Корпорейшн |
Клональные штаммы аттенуированных вакцинирующих вирусов и способы их использования
|
TWI497333B
(zh)
|
2011-06-14 |
2015-08-21 |
Giant Mfg Co Ltd |
自行車適配產生方法、自行車適配系統與電腦程式產品
|
EP2773366B1
(en)
|
2011-11-04 |
2017-03-01 |
Lipotec, S.A. |
Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
|
EP2788013A4
(en)
|
2011-12-09 |
2015-08-19 |
Stealth Peptides Int Inc |
AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US9104666B2
(en)
|
2012-09-04 |
2015-08-11 |
Oracle International Corporation |
Controlling access to a large number of electronic resources
|
FR2998570B1
(fr)
|
2012-11-26 |
2016-12-02 |
Sederma Sa |
Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes
|
WO2014120837A2
(en)
|
2013-01-29 |
2014-08-07 |
The Regents Of The University Of California |
Pretargeted activatable cell penetrating peptide with intracellulary releaseable prodrug
|
US20140227174A1
(en)
|
2013-02-11 |
2014-08-14 |
The Regents Of The University Of California |
Skin permeating and cell entering (space) peptides and methods of use therefor
|
WO2014123543A2
(en)
|
2013-02-11 |
2014-08-14 |
Convoy Therapeutics |
Skin permeating and cell entering (space) peptides and methods of use therefor
|
US20140234275A1
(en)
|
2013-02-15 |
2014-08-21 |
Jason Williams |
Method for treating als via the increased production of factor h
|
US10577303B1
(en)
|
2013-03-14 |
2020-03-03 |
Wisconsin Alumni Research Foundation |
Reagents and methods for esterification
|
US10287331B2
(en)
|
2013-04-15 |
2019-05-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Mitochondrial proteins constructs and uses thereof
|
EP2792684A1
(en)
|
2013-04-15 |
2014-10-22 |
Lipotec, S.A. |
Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions
|
WO2014190257A2
(en)
|
2013-05-23 |
2014-11-27 |
Ohio State Innovation Foundation |
Chemical synthesis and screening of bicyclic peptide libraries
|
US10293020B2
(en)
|
2013-06-27 |
2019-05-21 |
Stealth Biotherapeutics Corp. |
Peptide therapeutics and methods for using same
|
GB2516045A
(en)
|
2013-07-09 |
2015-01-14 |
Neuro Bio Ltd |
Neurodegenerative disorders
|
EP3033056B1
(en)
|
2013-08-12 |
2020-01-15 |
3M Innovative Properties Company |
Peptides for enhancing transdermal delivery
|
US10736932B2
(en)
|
2014-05-20 |
2020-08-11 |
Ohio State Innovation Foundation |
Small molecule Ras inhibitors
|
JP6807831B2
(ja)
|
2014-05-21 |
2021-01-06 |
エントラーダ セラピューティクス,インコーポレイテッド |
細胞膜透過性ペプチド、並びにこの作製方法及び使用方法
|
US10815276B2
(en)
|
2014-05-21 |
2020-10-27 |
Entrada Therapeutics, Inc. |
Cell penetrating peptides and methods of making and using thereof
|
FR3021319B1
(fr)
|
2014-05-22 |
2018-08-31 |
Sederma |
Peptides, compositions les comprenant et utilisations notamment cosmetiques
|
WO2016033314A1
(en)
|
2014-08-27 |
2016-03-03 |
The Regents Of The University Of California |
Skin penetrating peptides (spps) and methods of use therefor
|
US10258695B2
(en)
|
2014-09-04 |
2019-04-16 |
Wisconsin Alumni Research Foundation |
Protein derivatization to endow cell penetration
|
US10385380B2
(en)
|
2014-10-02 |
2019-08-20 |
The Regents Of The University Of California |
Personalized protease assay to measure protease activity in neoplasms
|
JP6882978B2
(ja)
|
2014-10-29 |
2021-06-02 |
バイスクルアールディー・リミテッド |
Mt1−mmpに特異的な二環性ペプチドリガンド
|
GB2539161A
(en)
|
2014-11-26 |
2016-12-14 |
Neuro-Bio Ltd |
Neurodegenerative disorders
|
FR3029782B1
(fr)
|
2014-12-16 |
2019-06-07 |
Sederma |
Composes peptidiques, compositions les comprenant et utilisations notamment cosmetiques
|
EP3936141A3
(en)
|
2015-01-23 |
2022-03-23 |
Erasmus University Rotterdam Medical Center |
Anti-senescence compounds and uses thereof
|
WO2016164622A1
(en)
|
2015-04-09 |
2016-10-13 |
Wisconsin Alumni Research Foundation |
Reagents and methods for esterification
|
US10596259B2
(en)
|
2015-05-20 |
2020-03-24 |
The Regents Of The University Of California |
Tumor radiosensitization with monomethyl auristatin E (MMAE) and derivatives thereof
|
WO2017048812A1
(en)
|
2015-09-15 |
2017-03-23 |
The Regents Of The University Of California |
Skin-penetrating peptides and compositions and methods of use thereof
|
HRP20220156T1
(hr)
|
2015-09-17 |
2022-04-15 |
Modernatx, Inc. |
Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
|
MA47016A
(fr)
|
2015-10-22 |
2018-08-29 |
Modernatx Inc |
Vaccins contre les virus respiratoires
|
GB201607827D0
(en)
|
2016-05-04 |
2016-06-15 |
Bicycle Therapeutics Ltd |
Bicyclic peptide-toxin conjugates specific for MT1-MMP
|
TWI781963B
(zh)
|
2016-11-09 |
2022-11-01 |
俄亥俄州立創新基金會 |
含二硫化物細胞穿透肽及其製造與使用方法
|
US10913773B2
(en)
|
2016-11-22 |
2021-02-09 |
Ohio State Innovation Foundation |
Bicyclic peptidyl inhibitor of tumor necrosis factor-alpha
|
US11352394B2
(en)
|
2016-11-22 |
2022-06-07 |
Ohio State Innovation Foundation |
Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof
|
US20190309020A1
(en)
|
2016-11-22 |
2019-10-10 |
Ohio State Innovation Foundation |
Cell-penetrating peptide sequences
|
US10624968B2
(en)
|
2017-01-06 |
2020-04-21 |
Bicyclerd Limited |
Compounds for treating cancer
|
US20220273664A1
(en)
|
2017-06-23 |
2022-09-01 |
The Governing Council Of The University Of Toronto |
Mitochondrial Targeted Releasable Linker
|
AU2018298892B2
(en)
|
2017-07-13 |
2022-06-23 |
Michael David FORREST |
Therapeutic modulators of the reverse mode of atp synthase
|
CA3078504A1
(en)
|
2017-10-04 |
2019-04-11 |
Ohio State Innovation Foundation |
Bicyclic peptidyl inhibitors
|
US11576946B2
(en)
|
2018-01-29 |
2023-02-14 |
Ohio State Innovation Foundation |
Peptidyl inhibitors of calcineurin-NFAT interaction
|
US11793884B2
(en)
|
2018-01-29 |
2023-10-24 |
Ohio State Innovation Foundation |
Cyclic peptidyl inhibitors of CAL-PDZ binding domain
|
FR3077202B1
(fr)
|
2018-02-01 |
2020-01-10 |
Sederma |
Utilisation de cyclopeptides en cosmetique
|
US11738093B2
(en)
|
2018-04-09 |
2023-08-29 |
Hope For Annabel |
AAV-mediated delivery of ATP1A3 genes to central nervous system
|
CA3050553A1
(en)
|
2019-07-25 |
2021-01-25 |
Michael D. Forrest |
Therapeutic modifiers of the reverse mode of atp synthase
|